ACGX | Alliance Creative Group, Inc. | Special Report

Alliance Creative Group, Inc. ACGX

We are revisiting ACGX this morning, to remind our readers why it still remains as one of the top stocks on our watchlist.

ACGX is a stock that boasts a skin-tight share structure, and as such, is subject to heavy swings on relatively light volume. We love a good high-volatility stock like this one, as it tends to offer up frequent opportunities to capitalize on quick gains.

In our original report on ACGX, dated November 1st, we outlined the growth in the company’s bottom line as one of the stock’s main selling points. They had just announced $2.8 million in Q2 revenues, as well as a 30% increase in gross profits from the same period a year before. We subsequently stated that “we believe the positive growth will continue” as a result of streamlined services and an updated model. Our assertion was dead-on, as this morning we see a PR released pertaining to bolstered Q3 financials:

Alliance Creative Group (ACGX) Reports 24% increase in Revenue for Q3 2012 Compared to Q3 2011 and 60% Increase Since Q3 2010


Company Still on Pace to do Over $10,000,000 in Revenue for the Year

CHICAGO, Nov. 15, 2012 /PRNewswire via COMTEX/ — Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ended September 30, 2012 compared to the Three Months Ended September 30, 2011.

Revenues for the three months ended September 30, 2012 (“Third Quarter 2012”) were $2,728,327 compared with $2,193,593 for the three months ended September 30, 2011 (“Third Quarter 2011”). That is an increase of $534,734 or 24% for the quarter.

Gross Profits were $762,087 compared to $602,712. That is an increase of $159,375 or a 26%.increase. Net Incomes were $159,512 compared to $193,825 compared. That is a decrease of $37,313.

The total assets of the Alliance Creative Group as of 9/30/12 were 5,261,701 compared to 9/30/11 when they were $4,016,649. This is an increase of $1,245,052. The total outstanding shares as of November 13, 2012 are 12,349,477 with 12,207,502 of those shares in the float.

____

Apart from great news on the positive growth front, we’d like to point out the finer points of the ACGX chart this morning:

ACGX is trading in a tight channel with a solid level of support at a penny, and key resistance at the 200DMA (.0148) and 100DMA (.0174). There has been a notable increase in volume in the month of November, as investors have been accumulating the stock in much greater numbers.

Perhaps another key point to which we can attune our focus is something simple, yet encouraging- one that others may even have overlooked. CEO Steven St. Louis, in a press release from a few weeks ago, stated:“Our Q3 numbers will be released around the middle of November.” Here we are, November 15th, and the figures have indeed arrived. We really can’t say enough about a company and CEO that stay true to their word. So many times, investors are fleeced by outfits that are willing to re-negotiate the follow-through of their own timetables, that we forget the value of organizations that keep their word. Such a simple thing as that rare bit of timeliness and honesty, tells us everything we need to know about Alliance Creative Group, and the way they intend to conduct business moving forward.

With this type of continued dedication to acheiving its goals, the future for ACGX could be pretty bright.

____

ALLIANCE CREATIVE GROUP, Inc. (Stock Symbol: ACGX) is a printing, packaging and brand management marketing company. The Alliance Creative Group utilizes shared resources to create efficiencies between their projects and internal divisions to create quality results and long-term partnerships. The core business areas include creative and design services, printing and packaging, product fulfillment & logistics and strategic marketing. www.AllianceCreativeGroup.com.

GRNH, CBIS, ERBB & Today’s Extended Watchlist

GreenGro Technologies, Inc. GRNH

We’ve often used the old term “If it ain’t broke, don’t fix it” around here, and it certainly seems to apply to our medical marijuana plays. We continue to see these high-flyers churning out sizable gains, time and again.

Friday was another monumental session for our watchlist with both GRNH, and CBIS trading record volume. With that surge in trading, came breakouts for both stocks.

GRNH was up another 183% on Friday, closing at .085. This represents a 554% gain from the low of .013 back when we first issued our med. marijuana report (Oct. 16).

While not the first gains we’ve seen from GRNH, Friday’s were the largest we’ve seen to this point, and on more than 10X its average volume.

Barchart.com is currently giving GRNH a “100% Buy” Rating.

We don’t think it is very likely to see a big pullback following that type of momentum, however, in the event of a consolidation, we’d like to see support hold in the .05-.06 range.

____

Cannabis Science, Inc. CBIS

As stated above, CBIS had record volume day on Friday. The video chart we put out that morning pointed to the fact that we wanted to see a break past the 200DMA of .07, and it happened that very same afternoon.

The stock went on to hit a high of .10, and closed out strong at .09. Being as low as .04 following our Oct 16th report, the gains at Friday’s high represent a 150% move.

Like GRNH, the momentum on CBIS was off the charts on Friday, therefore we anticipate some carry-over into today’s session.

____

Tranzbyte Corp ERBB

ERBB is one of the few cannabis-related stocks that is trading sub-penny. On Friday, the stock closed at a major resistance point of .004 (200DMA).

The stock has bumped its head against that point on quite a few occasions this year. Each time, it has been unsuccessful at getting over that obstacle.

Passing the 200DMA would be a major push in the right direction for ERBB, and would open the door for its next leg up. We’ll be continuing to monitor the stock for just such an eventuality.

____
Extended Watchlist:

STLK, CGRA, ACGX, LUNL, CELGZ, INO,

Cannabis Science, Inc. | CBIS | This Morning’s Focus

Cannabis Science, Inc. CBIS

We’ve stuck with CBIS for quite some time now, well before our medical marijuana round-up report on October 16th. Since we first began following, there have been several opportunities to profit off of this play.

Based on the volume and momentum that have been picking up over the past few trading sessions, it would be no surprise to see this thing run even higher. From last week’s low of .045, to yesterday’s high of .073, marks a 62% gain, testing a new high since the month of June.

We’re well aware of the monumental gains that CBIS can bring to the table. From late last year to March, the stock traded in a range from .009-.245.

We have also provided a video presentation of the CBIS chart for your viewing convenience:

____
Extended Watchlist:
STLK, CGRA, ACGX, FRZT, SLGX, CYCA